Antibacterial Activity of an Ethyl Acetate Extract of Pseudomonas sp. UJ-6 against Methicillin-Resistant Staphylococcus aureus
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
In an effort to discover an alternative antibiotic for treating infections with methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas sp. UJ-6, a marine bacterium that exhibited antibacterial activity against MRSA, was isolated. The culture broth and its ethyl acetate extract exhibited bactericidal activity against MRSA. The extract also exhibited antibacterial activity against gram-negative bacteria, which were not susceptible to vancomycin. The treatment of MRSA with the extract resulted in abnormal cell lysis. The extract retained >95% of its anti-MRSA activity after heat treatment for 15 min at 121°C. Thus, although most antibiotics are unstable under conditions of thermal stress, Pseudomonas sp. UJ-6 produces a heat-stable anti-MRSA substance. The results of this study strongly suggest that Pseudomonas sp. UJ-6 can be used to develop a novel, heat-stable, broad-spectrum antibiotic for the treatment of MRSA infections.
Abstract
In an effort to discover an alternative antibiotic for treating infections with methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas sp. UJ-6, a marine bacterium that exhibited antibacterial activity against MRSA, was isolated. The culture broth and its ethyl acetate extract exhibited bactericidal activity against MRSA. The extract also exhibited antibacterial activity against gram-negative bacteria, which were not susceptible to vancomycin. The treatment of MRSA with the extract resulted in abnormal cell lysis. The extract retained >95% of its anti-MRSA activity after heat treatment for 15 min at 121°C. Thus, although most antibiotics are unstable under conditions of thermal stress, Pseudomonas sp. UJ-6 produces a heat-stable anti-MRSA substance. The results of this study strongly suggest that Pseudomonas sp. UJ-6 can be used to develop a novel, heat-stable, broad-spectrum antibiotic for the treatment of MRSA infections.
참고문헌 (35)
- Abad MJ, "Marine compounds and their antimicrobial activities, In Science against Microbial Pathogens: Communicating Current Research and Technological Advances", pp.1293~1306 (2011), Formatex Research
- Acebal C, "Two marine Agrobacterium producers of sesbanimide antibiotics", J Antibiot, 51, pp.64~67 (1998)
- Acebal C, "Agrochelin, a new cytotoxic antibiotic from a marine Agrobacterium: taxonomy, fermentation, isolation, physicochemical properties and biological activity", J Antibiot, 52, pp.983~987 (1999)
- Barna JCJ, "The structure and mode of action of glycopeptide antibiotics of the vancomycin group", Annu Rev Microbiol, 38, pp.339~357 (1984)
- Barsby T, "Bogorol A produced in culture by a marine Bacillus sp. reveals a novel template for cationic peptide antibiotics", Org Lett, 3, pp.437~440 (2001)
- Biabani MAF, "δ-Indomycinone: a new member of pluramycin class of antibiotics isolated from marine Streptomyces sp", J Antibiot, 50, pp.874~877 (1997)
- 엄성환, "Antimicrobial Activity of Brown Alga Eisenia bicyclis against Methicillin-resistant Staphylococcus aureus", Fisheries and Aquatic Sciences, 14(4), pp.251~256 (2011), 한국수산과학회
- Eom SH, "In vitro antibacterial activity and synergistic antibiotic effects of phlorotannins isolated from Eisenia bicyclis against methicillin-resistant Staphylococcus aureus", Phytother Res (2012)[DOI]
- Gerard JM, "Loloatins A-D, cyclic decapeptide antibiotics produced in culture by a tropical marine bacterium", J Nat Prod, 62, pp.80~85 (1999)
- Hanaki H, "Increase in glutamine-non-amidated muropeptides in the peptidoglycan of vancomycin-resistant Staphylococcus aureus strain Mu50", J Antimicrob Chemother, 42, pp.315~320 (1998)
- Hiramatsu K, "Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility", J Antimicrob Chemother, 40, pp.135~136 (1997)
- Hughes CC, "The marinopyrroles, antibiotics of an unprecedented structure class from a marine Streptomyces sp", Org Lett, 10, pp.629~631 (2008)
- Imamura N, "New anticancer antibiotics, pelagiomicins produced by a new marine bacterium Pelagiobacter variabilis", J Antibiot, 50, pp.8~12 (1997)
- Isnansetyo A, "MC21-A, a bactericidal antibiotic produced by a new marine bacterium, Pseudoalteromonas phenolica sp. nov. O-BC30T, against methicillin-resistant Staphylococcus aureus", Antimicrob Agents Chemother, 47, pp.480~488 (2003)
- Isnansetyo A, "Anti-methicillin-resistant Staphylococcus aureus (MRSA) activity of MC21-B, an antibacterial compound produced by the marine bacterium Pseudoalteromonas phenolica O-BC30T", Int J Antimicrob Agents, 34, pp.131~135 (2009)
- Jevons MP, "“Celbenin”-resistant Staphylococci", Br Med J, 1, pp.124~125 (1961)
- Kamei Y, "Lysis of methicillin-resistant Staphylococcus aureus by 2,4-diacetylphloroglucinol produced by Pseudomonas sp. AMSN isolated from a marine alga", Int J Antimicrob Agents, 21, pp.71~74 (2003)
- Keller S, "Abyssomicins G and H and atrop-abyssomicin C from the marine Verrucosispora strain AB-18-032", J Antibiot, 60, pp.391~394 (2007)
- Kwon HC, "Marinomycins A-D, antitumor-antibiotics of a new structure class from a marine actinomycete of the recently discovered genus “Marinispora”", J Am Chem Soc, 128, pp.1622~1632 (2006)
- Lee DH, "Successful treatment of methicillin-resistant Staphylococcus aureus meningitis with daptomycin", Clin Infect Dis, 47, pp.588~590 (2008)
- 이대성, "Synergistic Effect between Dieckol from Ecklonia stolonifera and β-Lactams against Methicillin-resistant Staphylococcus aureus", Biotechnology and Bioprocess Engineering, 13(6), pp.758~764 (2008), 한국생물공학회
- Lee DS, "Anti-methicillin-resistant Staphylococcus aureus (MRSA) substance from the marine bacterium Pseudomonas sp. UJ-6", Environ Toxicol Pharmacol, 35, pp.171~177 (2013)
- Levy SB, "Antibiotic resistance-the problem intensifies", Adv Drug Deliv Rev, 57, pp.1446~1450 (2005)
- Macherla VR, "Lipoxazolidinones A, B, and C: antibacterial 4-oxazolidinones from a marine actinomycete isolates from a Guam marine sediment", J Nat Prod, 70, pp.1454~1457 (2007)
- Martín J, "Kocurin, the true structure of PM181104, an anti-methicillin-resistant Staphylococcus aureus (MRSA) thiazolyl peptide from the marine-derived bacterium Kocuria palustris", Mar Drugs, 11, pp.387~398 (2013)
- McArthur KA, "Lynamicins A-E, chlorinated bisindole pyrrole antibiotics from a novel marine actinomycete", J Nat Prod, 71, pp.1732~1737 (2008)
- Micek ST, "Alternatives to vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections", Clin Infect Dis, 45, pp.S184~S190 (2007)
- National Committee for Clinical Laboratory Standards, "Method for Dilution Antimicrobial Susceptibility Testing for Bacteria That Grow Aerobically: Approved Standard", NCCLS Document M7-A6, ~ (2004)
- Pusecker K, "Dihydrophencomycin methyl ester, a new phenazine derivative from a marine Streptomycete", J Antibiot, 50, pp.479~483 (1997)
- Rahman H, "Novel anti-infective compounds from marine bacteria", Mar Drugs, 8, pp.498~518 (2010)
- Schaberg DR, "Major trends in the microbial etiology of nosocomial infection", Am J Med, 91, pp.72S~75S (1991)
- Shiozawa H, "Thiomarinols D, E, F and G, new hybrid antimicrobial antibiotics produced by a marine bacterium: isolation, structure, and antimicrobial activity", J Antibiot, 50, pp.449~452 (1997)
- Totsuka K, "Combined effects of vancomycin and imipenem against methicillin-resistant Staphylococcus aureus (MRSA) in vitro and in vivo", J Antimicrob Chemother, 44, pp.455~460 (1999)
- Witte W, "Antibiotic resistance in gram-positive bacteria: epidemiological aspects", J Antimicrob Chemother, 44, pp.1~9 (1999)
- Woodford N, "Biological counterstrike: antibiotic resistance mechanisms of Gram-positive cocci", Clin Microbiol Infect, 11, pp.2~21 (2005)
